Overview
For temporary relief of nervousness, anxiety, mood swings, joint pains, weakness, drowsiness, itching and lethargy. Not evaluated by the FDA, homeopathic product.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Research Report
A Comprehensive Pharmacological and Clinical Review of Serotonin (5-Hydroxytryptamine)
Executive Summary
Serotonin, or 5-hydroxytryptamine (5-HT), is a phylogenetically ancient and biologically ubiquitous monoamine that functions as a neurotransmitter, hormone, and paracrine signaling molecule. While colloquially known as the "happiness hormone" for its profound influence on mood and behavior within the central nervous system (CNS), its physiological roles extend far beyond the brain. The vast majority of the body's serotonin is synthesized and acts within the gastrointestinal tract, where it is a master regulator of motility, secretion, and sensation. This comprehensive review synthesizes the current scientific understanding of serotonin, beginning with its fundamental molecular identity and physicochemical properties. It traces the historical arc of its discovery, which presciently began in the gut and blood before its role in the brain was elucidated, mirroring the modern appreciation of the gut-brain axis.
The report details the complete life cycle of endogenous serotonin, from its biosynthesis from the essential amino acid L-tryptophan to its catabolism by monoamine oxidase. A central theme is the functional segregation of the central and peripheral serotonin pools by the blood-brain barrier, a division that presents significant challenges for systemic pharmacotherapy. The diverse and often paradoxical functions of serotonin—regulating everything from blood clotting and vascular tone to sleep, appetite, and sexual function—are explained through the lens of its complex receptor system. With at least 14 distinct receptor subtypes belonging to seven families, the physiological effect of serotonin is dictated not by the molecule itself, but by the specific receptor and signaling cascade activated in a given tissue.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/07/16 | Not Applicable | Not yet recruiting | Medipol University | ||
2025/05/02 | Not Applicable | Active, not recruiting | Asad Ullah Jan | ||
2024/12/18 | Phase 4 | Recruiting | Tongji University | ||
2024/06/13 | Not Applicable | Active, not recruiting | |||
2024/06/11 | Not Applicable | Completed | |||
2023/03/27 | Not Applicable | Not yet recruiting | |||
2023/03/20 | N/A | ENROLLING_BY_INVITATION | |||
2023/01/31 | Not Applicable | Recruiting | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||
2022/01/06 | Phase 4 | Completed | All India Institute of Medical Sciences, Bhubaneswar | ||
2021/09/21 | N/A | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Dr. Donna Restivo DC | 62185-0059 | ORAL | 8 [hp_X] in 1 mL | 5/23/2025 | |
BioActive Nutritional, Inc. | 43857-0245 | ORAL | 6 [hp_X] in 1 mL | 5/21/2025 | |
Deseret Biologicals, Inc. | 43742-2276 | ORAL | 6 [hp_X] in 1 mL | 5/7/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
No Health Canada approvals found for this drug. |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.